Vision and Hearing During Deferoxamine Therapy
J Pediatr 117:326-330, Cohen,A.,et al, 1990
Muscle Stiffness, Gait Instability, and Liver Cirrhosis in Wilsons Disease
Lancet 396:990, Kronlage, C.,et al, 2020
High Doses of Deferiprone May Be Associated with Cerebellar Syndrome
BMJ 338:653, Beau-Salinas,F.,et al, 2009
Pre- and Posttreatment MR Imaging Findings in Lead Encephalopathy
AJNR 27:902-903, Atre,A.L.,et al, 2006
Aggressive Approach in the Treatment of Acute Lead Encephalopathy with an Extraordinarily High Concentration of Lead
Arch Pediatr Adolesc Med 152:1100-1104, Gordon,R.A.,et al, 1998
Serial Studies of Auditory Neurotoxicity in Patients Receiving Deferoxamine Therapy
Am J Med 83:1085-1090, Gallant,T.,et al, 1987
Lead Poisoning
NEJM 388:e63, Dhar,S. & Garg,D., 2023
Current and Emerging Issues in Wilsons Disease
NEJM 389:922-938, Roberts,E.A. & Schilsky, M.L., 2023
Peripheral Neuropathy - Lead Astray?
LANCET 381:1156, Pickrell, W.,et al, 2013
Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
NEJM 327:1473-1477, Gordeuk,V.,et al, 1992
Intramuscular Desferrioxamine in Patients with Alzheimer's Disease
Lancet 337:1304-1308, McLachlan,D.R.C.,et al, 1991